Is Karyopharm Therapeutics Kpti Stock Rebounding Price At 5.89 Up 1.20 20260402 What shapes market opinion on IDEA Group AMTD stock Q4 2020 EPS Beats Forecasts AHMA Ambitions management highlights stable core business fundamentals amid broader macroeconomic sector headwinds Is Aura Bio AURA a value trap or a value play Momentum Fading 20260506 US Treasury Secretary Bessent Signals Openness to AI Talks with China Cites American Leadership elf Beauty ELF Q1 2026 Earnings Surprise EPS 124 Up Significant Wholesale Inflation Accelerates in April Notching 6 Annual Gain Highest Since 2022 Analyst Report Revisits Amgen Incs Strategic Position in Biopharma Onfolio Shares Tumble After Quarterly Revenue Decline Despite Cost Efficiency Push Anavex AVXL Slides 103 as Selling Pressure Mounts 20260518 Fed Chair Powell Vows No Shadow Chair Role But Clash With Warsh Looms as Historic Meeting Approaches Samsung Strike Suspended as Union Members Vote on AI Bonus Deal Should You Sell Popular Pref BPOPM After 075 Drop 20260520 US Retail Sales Stall in December Signaling Potential Economic Slowdown Federal Reserves Path to Rate Cuts Narrowing Amid Persistent Cost of Living Pressures Roivant Shares Surge as Company Reports Swing to Profitability Bernstein Expresses Bullish View on American Tower Corporation AMT SpaceX Successfully Launches Starship V3 the Most Powerful Rocket Ever Built HealthEquity HQY Falls 28 Key Support in Focus as Momentum Fades Law Firm Kirkland Ellis Commits 500 Million to Develop Proprietary AI Platform OSG Q1 2026 Earnings Staggering EPS Surprise of 2334 Highlights Strong Underlying Performance Asias Wealthy Families Grapple with Succession Planning Survey Reveals CCL Q1 2026 Earnings EPS Surpasses Estimates as Cruise Demand Remains Robust SCI Q1 2026 Earnings EPS Misses Estimates Stock Declines BCSF Q1 2026 Earnings EPS Misses Expectations by 273 as Stock Slightly Declines SJM Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution Outlook Therapeutics Q1 2026 Earnings DeeperthanExpected Loss as PreRevenue Biotech Advances Pipeline OPKO Health Q1 2026 Earnings Narrow EPS Beat Lifts Shares 21 Amid Quiet Revenue Quarter EYPT Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue Ferrovial FER Q4 2025 Earnings EPS Beats Estimates by 526 Stock Slips Despite Strong Profit Performance KALU Q1 2026 Earnings Massive EPS Beat Highlights Operational Strength Federal Reserve Dissenters Explain Votes Against Statement Hinting at Next Rate Cut